Conversely, two recent translational studies showed a lower expression of MT1 and MT2 receptors in colon cancer tissues compared to matched normal tissues, suggesting melatonin’s protective role in colon cancer development [159,160]. This evidence concerns the gene MTNR1A and colonic neoplasm.